Aegis Lifesciences happy to share their presence at Hospitalar 2022

  Clefts of the lip, alveolus, and palate are among the most common craniofacial birth abnormalities found in both humans and animals. Traditional treatments, such as autogenous bone grafts, have long been regarded as the gold standard. However, these methods have substantial disadvantages, including limited bone availability and donor-site problems such as post-operative pain, changes in sensation, and the risk of infections and scarring. Fortunately, recent approaches in cell therapy and tissue engineering provide promising solutions to these issues. One interesting strategy is to use a gelatin sponge scaffold combined with cultured stem cells to repair cleft alveoli in dogs. In this blog, we’ll explore how combining these innovative approaches particularly utilizing a gelatin sponge scaffold with cultured stem cells, can revolutionize the treatment of craniofacial defects in dogs. Role of Gelatin Sponge, Cell therapy, and Tissue Engineering Gelatin Sponge Scaffold:  The gel...

  Effective   bleeding control   remains a formidable challenge in   modern surgery , particularly in orthopedic procedures where managing bleeding from the exposed or cut surface of cancellous bone is a critical concern.   Total knee arthroplasty   (TKA), a prevalent surgery for severe knee arthritis within orthopedics, is notably associated with significant blood loss due to extensive bone cutting and exposure of a large surface area of cancellous bone [1]. Challenges in TKA: Patients undergoing primary TKA are particularly susceptible to significant intraoperative and postoperative blood loss, leading to potential complications such as pain, decreased range of motion, and delayed recovery. With an aging population and increased life expectancy, the annual incidence of TKA procedures is expected to rise, reaching an estimated 3 million in the United States by 2030 [2]. Role of Absorbable Haemostatic Agents: To address bleeding challenges in orthopedic sur...

  The most recent report from  360iResearch , featured on  openPr.co  unveils a significant surge in the Topical Haemostat Market, outlining a remarkable growth trajectory. This dynamic report, titled “Topical Haemostat Market by Product (Collagen-Based Topical Haemostats, Combination Topical Haemostats, Gelatin-Based Topical Haemostats), Application (Hospitals, Nursing Homes, Surgical Centers) –  Global Forecast 2023-2030 ,” presents an in-depth analysis and forecasting of the market landscape. Market Projections and Growth Dynamics The report projects substantial growth in the Topical Haemostat Market, foreseeing a robust increase from USD 3.81 billion in 2022 to a remarkable USD 6.84 billion by 2030. This growth trajectory reflects a commendable compound annual growth rate (CAGR) of 7.57%. Such expansion is driven by escalating demands across various applications within the medical sphere for effective haemostatic solutions. FPNV Positioning Matrix and Market...

  Aegis Lifesciences Private Ltd proudly showcased its cutting-edge medical devices at  Medica 2023  in  Dusseldorf , the largest  international trade fair for medical devices . The company’s booth was a hub of activity, attracting a multitude of visitors eager to explore and inquire about Aegis’ diverse range of products, including Absorbable Haemostats such as  Absorbable Gelatin Sponge ,  Oxidized Regenerated Cellulose ,  Hemostatic powder ,  Flowable Haemostats , and  PVA sponges . The enthusiastic response from attendees underscored the global interest in Aegis’ innovative solutions. It was particularly heartening to witness a significant representation of Indian companies at the event, reflecting the industry’s growing prominence on the international stage. Aegis Lifesciences  continues to be a trailblazer in the field, fostering connections and driving advancements in  Haemostatic product technology.

  Are you ready to witness the future of hemostatic solutions? Aegis Lifesciences Pvt. Ltd. is excited to invite you to be a part of a groundbreaking experience at  MEDICA 2023 , the world’s premier medical exhibition held in Düsseldorf, Germany. The whole world of medical devices meets here MEDICA in Düsseldorf is one of the largest medical B2B trade fairs in the world. A wide range of innovative  surgical & medical products  and services from all fields like medical consumables, surgical dressings, biosimilars, regenerative devices, wound care, and dental products are presented here. It’s the ideal platform for  hemostatic product manufacturers and suppliers  to showcase their latest offerings, forge invaluable connections, and access a global audience of healthcare professionals. Gear up for the ultimate showcase of hemostatic prowess. Unveil the latest breakthroughs, connect with top-tier experts, and revolutionize your approach ...